Kenvue Inc. (KVUE) fair value analysis
S&P 500 · Updated 2026-10-19
KVUE price how computed
Forward Fair Value verdict
UndervaluedKVUE is trading at a 10–25% discount to estimated fair value.
Based on TickrTrends' weekly Forward Fair Value model.
- Last price
- $17.70
- Sector
- Consumer Defensive
- 12-month range
- $14.24–$19.83
- Market cap
- $34B
- From 52-week high
- -10.7%
- Shares outstanding
- 1.92B
- Rank in Consumer Defensive by discount to fair value
- #26 of 61
Last price is our 2026-10-19 weekly price; the chart runs through 2026-10-16.
Kenvue Inc. is a consumer health company that manufactures and markets over-the-counter medicines, vitamins, and personal care products sold under well-known brand names. The company operates globally, selling its products across North America, Europe, Asia, and other international markets.
KVUE currently ranks #26 of 61 Consumer Defensive stocks by discount to fair value. It has screened as Undervalued for 11 consecutive weekly runs.
Fundamentals (4 quarters) how computed
- Market cap
- $34B
- P/E (trailing)
- 15x
- Revenue (TTM)
- $15.4B
- Net margin
- 10.8%
- EPS (TTM)
- $1.18
- Gross margin
- 58.2%
- Debt / equity
- 0.80
- Revenue growth (3-yr avg)
- 0.3%
- Shares outstanding
- 1.92B
Derived indicators how computed
- Quality grade
- C
- Margin trend
- Stable
- 52-week position
- The upper-middle quarter of its range
- DCF cross-check
- Overvalued
Technicals how computed
- RSI (14-day)
- 72 · overbought
- 50-day average
- $18.34
- 200-day average
- $18.07
- Moving-average state
- 50-day above 200-day (golden cross state); price between the averages
Dividends how computed
- Paid, last 12 months
- $1.04 per share (5 payments)
- Yield on last price
- 5.89%
- Consecutive years of increases
- 2
- Last ex-dividend date
- 2026-09-21
- Last payment date
- 2026-10-02
Earnings how computed
- Next earnings report
- 2026-11-02
- Last 8 quarters vs consensus
- 6 beat, 1 missed
- Quarter by quarter
- 2026-06 ▼ miss (-3.1%)
2026-03 ▲ beat (+23.1%)
2025-12 ▲ beat (+22.7%)
2025-09 ▲ beat (+7.7%)
2025-06 ▲ beat (+3.6%)
2025-03 ▲ beat (+4.3%)
2024-12 ▬ met (0.0%)
2024-09 ▲ beat (+3.7%)
Analyst consensus how computed
This is not TickrTrends' verdict.
- Analyst ratings
- 2 buy · 12 hold · 0 sell (14 analysts)
- Consensus lean
- Hold-leaning
- Consensus price target
- $19.5
- Target vs last price
- +10.2%
What our data shows for KVUE
- Our model validated 12 trailing price-to-earnings windows for KVUE, built from quarterly earnings records.
- Shares are trading in the middle of their 12-month price range of $14.24–$19.83.
- The 14-day relative strength index sits at an overbought 72.
The exact numbers are one step away
- The precise Forward Fair Value dollar figure for KVUE
- Exact discount / premium to today's price
- The normalized historical P/E behind the estimate, and how many quarters support it
- Forward EPS input and fiscal-year basis
- Screeners and rankings across the full S&P 500 and Nasdaq universes
Forward Fair Value applies a conservatively normalized historical price-to-earnings multiple to the consensus earnings estimate for the next full fiscal year; how TickrTrends computes it.
What people are saying
Follow the KVUE conversation: Stocktwits · Reddit · X
TickrTrends weekly updates
- 2026-10-19 — KVUE's technical indicators shifted this week as the Relative Strength Index moved from neutral territory into overbought zone. The stock maintains an undervalued valuation verdict within the Consumer Defensive sector. This overbought reading suggests the stock has experienced upward momentum that may warrant monitoring for potential pullback or consolidation.
- 2026-10-12 — No material change this week: the verdict, bands and grades all held steady.
- 2026-10-11 — No material change this week: the verdict, bands and grades all held steady.
- 2026-10-10 — No material change this week: the verdict, bands and grades all held steady.
- 2026-10-06 — No material change this week: the verdict, bands and grades all held steady.
- 2026-09-28 — KVUE's position within the Consumer Defensive sector has shifted this week, with its sector discount rank declining from 33 to 39. The company maintains an undervalued assessment according to TickrTrends' derived indicators. This change reflects a relative shift in KVUE's valuation standing compared to other companies in its sector.
- 2026-09-21 — No material change this week: the verdict, bands and grades all held steady.
- 2026-09-17 — No material change this week: the verdict, bands and grades all held steady.
Frequently asked questions
Is KVUE stock undervalued?
Based on TickrTrends' Forward Fair Value model (updated 2026-10-19), KVUE is trading at a 10–25% discount to estimated fair value and screens as undervalued. The exact fair value and discount are available to subscribers.
What is KVUE's TickrTrends verdict?
KVUE's current verdict is Undervalued, refreshed with every weekly Forward Fair Value run.
How does KVUE compare to other Consumer Defensive stocks?
KVUE ranks #26 of 61 Consumer Defensive stocks in TickrTrends' coverage by discount to fair value.
Is KVUE overbought or oversold?
KVUE's 14-day RSI is in the overbought zone on TickrTrends' latest weekly data.
Does KVUE pay a dividend?
Yes. KVUE paid $1.04 per share over the last twelve months (5 payments), a 5.89% yield on TickrTrends' last price, and has raised the annual total for 2 consecutive years. The last ex-dividend date was 2026-09-21.
When does KVUE report earnings next?
KVUE's next earnings report is scheduled for 2026-11-02, per the published earnings calendar.
Does KVUE usually beat earnings estimates?
Over its last 8 reported quarters KVUE beat the consensus estimate 6 times and missed 1 times, by TickrTrends' comparison of reported and estimated EPS.
What do analysts say about KVUE?
Of 14 analysts covering KVUE, 2 rate it a buy, 12 a hold and 0 a sell - hold-leaning, with a consensus price target of $19.5 (+10.2% versus TickrTrends' last price). This is the analyst consensus, not TickrTrends' Forward Fair Value verdict.
More in Consumer Defensive
Head-to-head comparisons
KVUE vs ANDE · KVUE vs APEI · KVUE vs CENTA · KVUE vs CHD · KVUE vs CL